S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

ALPS Medical Breakthroughs ETF Stock Forecast, Price & News

-0.49 (-1.05 %)
(As of 10/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume4,711 shs
Average Volume25,213 shs
Market Capitalization$206.85 million
P/E RatioN/A
Dividend Yield0.00%
30 days | 90 days | 365 days | Advanced Chart
Receive SBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Alps
Fund NameALPS Medical Breakthroughs ETF
Tax ClassificationRegulated Investment Company
Inception Date12/31/2014
Fund ManagerRyan Mischker, Andrew Hicks

Fund Focus

Asset ClassEquity
BenchmarkPoliwogg Medical Breakthroughs Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$206.69 million
Average Daily Volume$10,212.30

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorALPS Fund Services, Inc.
AdvisorALPS Advisors, Inc.
CustodianState Street Bank and Trust Company
DistributorALPS Portfolio Solutions Distributor, Inc.
Transfer AgentState Street Bank and Trust Company
Lead Market MakerCantor Fitzgerald

Geographic Exposure of SBIO

Currency Exposure of SBIO

Sector Exposure of SBIO

Industry Exposure of SBIO

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Frequently Asked Questions

What stocks does MarketBeat like better than ALPS Medical Breakthroughs ETF?

Wall Street analysts have given ALPS Medical Breakthroughs ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ALPS Medical Breakthroughs ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ALPS Medical Breakthroughs ETF's stock been impacted by COVID-19 (Coronavirus)?

ALPS Medical Breakthroughs ETF's stock was trading at $33.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SBIO shares have increased by 36.8% and is now trading at $45.9670.
View which stocks have been most impacted by COVID-19

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), (MRNA), Novavax (NVAX), (SNY), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX).

What is ALPS Medical Breakthroughs ETF's stock symbol?

ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SBIO."

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ALPS Medical Breakthroughs ETF's stock price today?

One share of SBIO stock can currently be purchased for approximately $45.97.

How much money does ALPS Medical Breakthroughs ETF make?

ALPS Medical Breakthroughs ETF has a market capitalization of $206.85 million.

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.